Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
| Record | Firm | Date |
|---|---|---|
| A Compassionate Use (CU) Program of Odronextamab (NCT05619367) | Regeneron Pharmaceuticals |
Track Relapsed or Refractory (R/R) Follicular Lymphoma (FL) automatically
Every clearance here is in the API, with alerts when new ones post.